2025 annual financial data
Radiopharm Theranostics 2025 Financial results
Direct answer
Revenue was 3,633,422 AUD.
Operating income was -38,173,865 AUD and net income was -38,342,457 AUD.
Operating cash flow was -36,645,477 AUD.
Get free Radiopharm Theranostics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,633,422 AUD
- Operating income
- -38,173,865 AUD
- Net income
- -38,342,457 AUD
- Operating cash flow
- -36,645,477 AUD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Radiopharm Theranostics financial years